SIBN 📈 Si-Bone - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8257041090
SIBN: Surgical Implants, Bone Products, Medical Devices
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Web URL: https://si-bone.com
Additional Sources for SIBN Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SIBN Stock Overview
Market Cap in USD | 569m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 2018-10-17 |
SIBN Stock Ratings
Growth 5y | -47.5% |
Fundamental | -37.5% |
Dividend | - |
Rel. Strength Industry | -1588 |
Analysts | 4.56/5 |
Fair Price Momentum | 10.86 USD |
Fair Price DCF | - |
SIBN Dividends
No Dividends PaidSIBN Growth Ratios
Growth Correlation 3m | -4.9% |
Growth Correlation 12m | -71% |
Growth Correlation 5y | -41.4% |
CAGR 5y | -8.64% |
CAGR/Mean DD 5y | -0.23 |
Sharpe Ratio 12m | -0.74 |
Alpha | -72.99 |
Beta | 1.47 |
Volatility | 51.05% |
Current Volume | 519.2k |
Average Volume 20d | 291.5k |
What is the price of SIBN stocks?
As of December 22, 2024, the stock is trading at USD 13.25 with a total of 519,180 shares traded.
Over the past week, the price has changed by -4.11%, over one month by +5.93%, over three months by -17.56% and over the past year by -34.68%.
As of December 22, 2024, the stock is trading at USD 13.25 with a total of 519,180 shares traded.
Over the past week, the price has changed by -4.11%, over one month by +5.93%, over three months by -17.56% and over the past year by -34.68%.
Is Si-Bone a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Si-Bone (NASDAQ:SIBN) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.47 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIBN as of December 2024 is 10.86. This means that SIBN is currently overvalued and has a potential downside of -18.04%.
Probably not. Based on ValueRay Fundamental Analyses, Si-Bone (NASDAQ:SIBN) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.47 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIBN as of December 2024 is 10.86. This means that SIBN is currently overvalued and has a potential downside of -18.04%.
Is SIBN a buy, sell or hold?
Si-Bone has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy SIBN.
Si-Bone has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy SIBN.
- Strong Buy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for SIBN stock price target?
According to ValueRays Forecast Model, SIBN Si-Bone will be worth about 12.2 in December 2025. The stock is currently trading at 13.25. This means that the stock has a potential downside of -7.77%.
According to ValueRays Forecast Model, SIBN Si-Bone will be worth about 12.2 in December 2025. The stock is currently trading at 13.25. This means that the stock has a potential downside of -7.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 23.2 | 75.2% |
Analysts Target Price | 28.4 | 114.2% |
ValueRay Target Price | 12.2 | -7.8% |